Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04804462 · ClinicalTrials.gov registry record · NA

Virtual Reality Meditation for Fatigue

A NA study of Rheumatoid Arthritis and Fatigue, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04804462: Completed NA study of Rheumatoid Arthritis and Fatigue, sponsored by University of Washington.

NCT04804462 is a NA study of Rheumatoid Arthritis and Fatigue that has completed, run by University of Washington. The registered enrollment target is 16 participants, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04804462, a NA study of Rheumatoid Arthritis and Fatigue, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This study will examine the feasibility and acceptability of using virtual reality (VR) meditation to manage fatigue in outpatients with rheumatoid arthritis (RA). The specific aims of this feasibility study include: 1) examining the feasibility of implementing VR meditation as an adjunct for managing fatigue in outpatients with rheumatoid arthritis; 2) determine the acceptability of using VR-delivered meditation training for fatigue management in outpatients with rheumatoid arthritis; and 3) is to explore outpatient's experience of using VR-delivered meditation to manage fatigue.

Primary Outcome

Completion percentage of quantitative questionnaires and an analysis of fidelity will provide insight into the feasibility of using virtual reality meditation for rheumatoid-arthritis related fatigue.

Interventions

  • DEVICE Virtual Reality Meditation

Study Locations (1)

Washington

  • Rheumatology Clinic at UW Medical Center - Roosevelt - Seattle

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2019-08-01
Est. Completion 2021-06-01
Phase NA
University of Washington

1,048 total trials

What the finished NCT04804462 record still lists

NCT04804462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality Meditation is the first listed.

NCT04804462 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT04804462 about?

NCT04804462 is a clinical study titled "Virtual Reality Meditation for Fatigue". This study will examine the feasibility and acceptability of using virtual reality (VR) meditation to manage fatigue in outpatients with rheumatoid arthritis (RA). The specific aims of this feasibility study include: 1) examining the feasibility of implementing VR meditation as an adjunct for managi...

What is the current status of trial NCT04804462?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-08-01. Estimated completion is 2021-06-01.

What conditions does trial NCT04804462 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Fatigue.

What interventions are being tested in trial NCT04804462?

The interventions under investigation include: Virtual Reality Meditation (DEVICE).

Who is sponsoring clinical trial NCT04804462?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04804462 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04804462's enrollment target sits among peer trials

16 186th of 197 higher than 12 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04804462, the US trial registry maintained by the National Library of Medicine. NCT04804462 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.